Navigation Links
Intel Corporation acquires Toronto start-up CognoVision
Date:11/16/2010

Intel Corporation acquires Toronto start-up CognoVision


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Internet Technology, Biotechnology, Acquisitions, Mergers and Takeovers Click to view news release full screen  

Intel Corporation acquires Toronto start-up CognoVision

 

To view the Social Media Release, click here: http://smr.newswire.ca/en/mars-discovery-district/intel-corporation-acquires-cogno-vision MaRS client delivers industry-defining technology for audience measurement and retail intelligence

TORONTO, Nov. 16 /PRNewswire/ - MaRS, a Toronto-based innovation centre, is pleased to announce that Intel Corporation has acquired CognoVision, one of its client companies. The CognoVision platform helps retailers and digital signage networks measure the effectiveness of in-store marketing and develop deeper insights into shopper behaviour. Terms of the transaction were not disclosed.

The CognoVision team has developed an innovative Anonymous Impression Metric (AIM) platform that provides powerful business intelligence metrics for digital signage networks and retailers. Its solutions allow digital signage networks to measure and maximize their ROI and retailers to improve their bottom line by increasing store sales and reducing costs. 

CognoVision's early beginnings were as students in the MaRS Entrepreneurship 101 Program. The company's three founders, Haroon Mirza, Dr. Shahzad Malik and Faizal Javer, became MaRS clients in 2006. Since then, several MaRS advisors and mentors have worked with the CognoVision team as they evolved their product and business strategy.

"We're grateful for the work that MaRS did over the years to help us move CognoVision from a concept to a rapidly growing business. The MaRS team have been a valuable extension of our own team and an integral part of our success," Mirza says.  "We've benefitted from guidance on our strategy, financing and marketing/sales at every stage of the company's development. They have also been very helpful in supporting us as we developed partner relationships here in Canada and abroad."

For MaRS, it's rewarding to see CognoVision's commercial success come to fruition. "CognoVision has made truly impressive progress refining its product and establishing a leading position in a highly competitive market since we first met their fledgling team through our Entrepreneurship 101 program," says MaRS CEO Dr. Ilse Treurnicht.  "They are a very inspiring example of Canada's entrepreneurial talent and passion.  I have no doubt that we will hear more from them in the future."About MaRS MaRS Discovery District (www.marsdd.com) is a large scale, mission driven innovation centre in Toronto, focused on building Canada's next generation of growth companies. MaRS works closely with entrepreneurs in life sciences and health care, information technology, communications and entertainment, clean tech, advanced materials and energy, as well as the social sector. 


'/>"/>
SOURCE MaRS Discovery District
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. A New BioPharma Intelligence Resource Set to Give Industry Leaders the Edge
2. iPierian Expands Leadership Team With Experienced Business Development and Intellectual Property Executives
3. DGP Group Rebrands as Intelsius and Announces Launch of New, Innovative Packaging System - Orcatherm™
4. TRINAMIC Teams with Actel's SmartFusion™ Intelligent Mixed Signal FPGAs for Motion Control
5. Maine Medical Center Chooses Business Intelligence Solution from Rapid Insight Inc.
6. Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing
7. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
8. BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool
9. Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property
10. Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
11. Intelligence inside metal components
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 21, 2017 , ... The Conference Forum has announced the launch of ... on May 10-11, 2017, at the Colonnade Hotel in Boston, MA. The CMO Summit ... peer-to-peer learning, benchmarking and support. , “The Chief Medical Officer faces a unique set ...
(Date:3/22/2017)... Milwaukee, WI (PRWEB) , ... March 22, 2017 , ... ... federal scientific research agencies as outlined in the Administration’s recently published fiscal year 2018 ... for the National Institutes of Health (NIH) by $5.8 billion or roughly 20% of ...
(Date:3/22/2017)... , March 22, 2017  Personal Genome ... its cancer testing contract with the U.S. Department ... tumor profiling assay with the company,s new CancerSELECT ... comprehensive, clinically actionable pan-cancer profiling test that includes ... assess potential patient response to checkpoint inhibitor immunotherapies. ...
(Date:3/20/2017)... ... , ... SSCI and Whitehouse Laboratories, divisions of Albany Molecular Research, Inc, are ... the Parenteral Drug Association (PDA), the New York Interphex Show will open on March ... more than 625 exhibitors, the educational and networking opportunities are extremely valuable. INTERPHEX is ...
Breaking Biology Technology:
(Date:3/7/2017)... , March 7, 2017 Brandwatch , the leading ... The Prince,s Trust to uncover insights to support its ... Trust. The UK,s leading youth charity will be using ... results and get a better understanding of the topics and issues ... ...
(Date:3/2/2017)... , March 2, 2017 Summary This ... Perrigo and its partnering interests and activities since 2010. ... Read the ... and Alliance since 2010 report provides an in-depth insight into ... sciences companies. On demand company reports are prepared ...
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
Breaking Biology News(10 mins):